Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study
Purpose. Dry eye disease (DED) can be triggered using preserved ophthalmic formulations or prostaglandin analogs. In this prospective, nonrandomized, open-label pilot study, we evaluated the efficacy of a 0.15% hyaluronic acid (HA) nonpreserved ophthalmic formulation in decreasing DED symptoms in pa...
Saved in:
Main Authors: | Giulia Coco, Danilo Iannetta, Igino Febbraro, Ester Elmo, Gianluca Manni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2022/1320996 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IOP-lowering effect and tolerability of prostaglandin analogues in primary open-angle glaucoma and ocular hypertension as risk factors for glaucoma progression
by: A.V. Belogurova, et al.
Published: (2019-04-01) -
Characteristics of glaucoma therapy with prostaglandin analogues nowadays
by: I.B. Alekseev, et al.
Published: (2022-09-01) -
The Effects of Trabeculectomy on Pseudoexfoliation Glaucoma and Primary Open-Angle Glaucoma
by: Fan Li, et al.
Published: (2020-01-01) -
Modalities for the treatment of primary open-angle glaucoma
by: Zh.G. Oganezova, et al.
Published: (2019-09-01) -
Epidemiological characterization of primary open-angle glaucoma
by: Leonor Rosario Díaz Alfonso, et al.
Published: (2010-11-01)